Chile ranks second globally in adolescent suicide rates, with 26.5% of teens showing moderate-to-severe depression/anxiety symptoms and suicide among top causes of death for ages 15-29. Treatment-resistant depression affects 25-40% of adolescents; TMS is FDA-approved for patients 15+ and achieves remission in 41% of cases and eliminates suicidal ideation in 60% of patients.
El Reportero de Iquique
· May 14, 2026
· health
· 3 min de lectura
High
Verificación: Caracterizado
Transcranial Magnetic Stimulation Offers Hope for Treatment-Resistant Depression in Chilean Youth
Youth suicide is among the leading causes of death for ages 15-29 in Chile, with 90% of cases linked to untreated mental illness; treatment-resistant depression significantly elevates suicide risk.
◉
Health & Medicine
2798 artículos relacionados
FDA approves Wegovy for heart disease prevention, expanding blockbuste…
infobae · 99% coincidencia
El ARN mensajero abre camino a vacunas contra 30 enfermedades infeccio…
infobae · 90% coincidencia
WHO endorses GLP-1 weight-loss drugs, issues first clinical guidance a…
El Tiempo · 90% coincidencia
Ozempic: Riesgos crecientes por uso estético sin supervisión médica
Medio digital El Zorro Nortino · 90% coincidencia
Weight-Loss Drugs Show Promise in Reducing Alcohol Cravings, But Clini…
infobae · 90% coincidencia
Cobertura Relacionada
El País · Aug 22
La personalidad Ozempic: cómo la delgadez extrema acaba con el placer
Usuarios de fármacos GLP-1 como Ozempic reportan anhedonia, un efecto secundario que les impide disfrutar de actividades…
CNN en Español · Aug 22 Moderna y Merck logran avance decisivo con vacuna personalizada contra el cáncerMerck y Moderna reportan éxito de una vacuna personalizada contra el melanoma que entrena el sistema inmunológico para a…
El Divisadero · Aug 21 Hepatitis virales: herramientas de prevención y cura al alcance en AysénGastroenterólogo del Hospital Regional Coyhaique explica las hepatitis virales, sus formas de transmisión y las herramie…
radiosantamaria.cl · Aug 21 Escuela España suspende clases por brote de enfermedades respiratorias en CoyhaiqueLa Escuela Diferencial España de Coyhaique suspendió clases por 48 horas tras confirmarse un brote de enfermedades respi…
Sesgo y Encuadre
⚖
Article uses crisis framing and emotional narratives to advocate for TMS as depression treatment, with selective statistics emphasizing severity but limited critical examination of TMS efficacy claims.
Bias Direction
center-left
Confidence
MED
Crisis narrative with human-interest storytelling. Opens with alarming statistics (75% of youth, suicide rates) to establish urgency, then presents TMS as solution. Uses emotional family testimony to create sympathy and validate the problem severity.
crisis de salud mental
grito desesperado
nada logra disminuir el dolor
han golpeado muchas puertas
silenciosa batalla
motivo de preocupación
Critical examination of TMS efficacy rates and long-term outcomes
Cost and accessibility barriers to TMS treatment in Chile
Perspectives from mental health professionals on TMS limitations
Alternative or complementary treatment approaches
Potential side effects or risks of TMS
Systemic factors contributing to mental health crisis (socioeconomic, educational)
Voices of adolescents themselves, not just parents
Impacto Geopolítico
🌎
Chile's youth mental health crisis (75% experiencing anxiety/depression) has geopolitical implications for regional healthcare policy and economic productivity, though primarily a domestic public health issue.
Escalation Risk
low
Confidence
LOW
Chile
Latin America
This article reflects Chile's positioning within OECD health metrics and WHO comparisons, potentially influencing regional health policy leadership and international development funding priorities in Latin America.
Lente Económico
📈
Chile's youth mental health crisis (75% experiencing anxiety/depression) creates economic opportunity for TMS treatment adoption, with potential healthcare cost savings from reduced suicide mortality and improved workforce productivity.
Market Signal
bullish
Confidence
MED
Healthcare/Medical devices
Mental health services
Pharmaceutical industry
Medical technology
Insurance/Healthcare financing
Education (productivity impacts)
Labor market (workforce participation)
Households face increased out-of-pocket healthcare costs for TMS treatment (typically not covered by basic insurance), but potential long-term savings from reduced hospitalizations, emergency care, and improved family economic productivity. Lower-income families may face access barriers.
Chilean government likely to consider: (1) TMS coverage expansion in public healthcare system; (2) Mental health budget reallocation; (3) Regulatory approval acceleration for neurotechnology devices; (4) Suicide prevention programs; (5) School-based mental health screening; (6) Potential subsidies for treatment-resistant depression cases to reduce suicide-related economic losses.